BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles in Press
    
        8/1/2022 4:09:47 AM | Browse: 93 | Download: 166
    
    
        
    
        | Category | Gastroenterology & Hepatology | 
    
        | Manuscript Type | Observational Study | 
    
        | Article Title | Clinical implications of interleukins-31, 32, and 33 in gastric cancer | 
    
        | Manuscript Source | Unsolicited Manuscript | 
    
        | All Author List | Qing-Hua Liu, Ji-Wei Zhang, Lei Xia, Steven G Wise, Brett David Hambly, Kun Tao and Shi-San Bao | 
    
        | Funding Agency and Grant Number | 
                        
                            
                                | Funding Agency | Grant Number |  
                                        | National Natural Science Foundation of China | 81502030 |  | 
    
        | Corresponding Author | Shi-San Bao, MD, PhD, Academic Fellow, Department of Pathology, Tongren Hospital, No. 1111 Xianxia Road, Changning Distric, Shanghai 200336, China. bob.bao@sydney.edu.au | 
    
        | Key Words | Diagnosis and therapy; Gastric cancer; Immune cell interactions; Interleukin-31; Interleukin 32; Interleukin-33 | 
    
        | Core Tip | Gastric cancer (GC) is one of the most common malignancies in China with a high morbidity and mortality. This study aimed to determine whether interleukin (IL)-31, IL-32, and IL-33 can be used as biomarkers for the detection of GC, via evaluating the correlations between their expression and clinicopathological parameters of GC patients. IL-31, IL-32, and IL-33 expression in GC was correlated with the severity of clinicopathological parameters. Circulating IL-33 was significantly low in GC patients. Our findings may provide new insights into the roles of IL-31, IL-32, and IL-33 in the carcinogenesis of GC. | 
    
        | Citation | Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS. Clinical implications of interleukins-31, 32, and 33 in gastric cancer. World J Gastrointest Oncol 2022; 14(9): 1808-1822 | 
    
    
        
    
        | 
                
                    |  | Received |  | 2022-02-28 23:24 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2022-02-28 23:26 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2022-04-17 04:50 | 
    
        | 
                
                    |  | Revised |  | 2022-04-21 14:14 | 
    
        | 
                
                    |  | Second Decision |  | 2022-07-29 02:52 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2022-08-01 04:09 | 
    
        | 
                
                    |  | Articles in Press |  | 2022-08-01 04:09 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  | 2022-07-25 10:50 | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2022-08-31 07:56 | 
        
        
            
                | ISSN | 1948-5204 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ | 
            
                | Copyright | ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
        
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345